| First-in-human trial of the oral ataxia telangiectasia and RAD3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumors TA Yap, DSP Tan, A Terbuch, R Caldwell, C Guo, BC Goh, V Heong, ... Cancer discovery 11 (1), 80-91, 2021 | 165 | 2021 |
| First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors. JS De Bono, DSP Tan, R Caldwell, A Terbuch, BC Goh, V Heong, ... Journal of Clinical Oncology 37 (15_suppl), 3007-3007, 2019 | 32 | 2019 |
| Abstract CT143: Phase I study of the combination of a RAF-MEK inhibitor CH5126766 and FAK inhibitor defactinib in an intermittent dosing schedule with expansions in KRAS mutant … R Shinde, A Terbuch, M Little, R Caldwell, R Kurup, R Riisnaes, M Crespo, ... Cancer Research 80 (16_Supplement), CT143-CT143, 2020 | 22 | 2020 |
| Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance C Guo, A Sharp, B Gurel, M Crespo, I Figueiredo, S Jain, U Vogl, ... Nature 623 (7989), 1053-1061, 2023 | 9 | 2023 |
| Targeting homologous recombination deficiency in uterine leiomyosarcoma G Dall, CJ Vandenberg, K Nesic, G Ratnayake, W Zhu, JHA Vissers, ... Journal of Experimental & Clinical Cancer Research 42 (1), 112, 2023 | 2 | 2023 |
| Abstract CT129: HyPeR: A phase 1, dose escalation and expansion trial of guadecitabine (SGI-110), a second-generation hypomethylating agent in combination with pembrolizumab … D Papadatos-Pastos, A Pal, M Akay, M Ameratunga, S Mithra, JE Ang, ... Cancer Research 80 (16_Supplement), CT129-CT129, 2020 | 2 | 2020 |
| Clinical impact of molecular profiling of cervical cancer (CC) patients (pts) in a dedicated phase I (P1) unit M Scaranti, R Caldwell, MS Miralles, R Shinde, A Pal, JE Ang, A Biondo, ... Annals of Oncology 30, v430, 2019 | 1 | 2019 |
| Regulatory approvals for genitourinary (GU) cancer by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) over 20 years (2003-2023). S Khanna, N Sarwar, R Caldwell, J Krell, DJ Benjamin, MJ Hadfield, ... Journal of Clinical Oncology 42 (4_suppl), 432-432, 2024 | | 2024 |
| Targeting homologous recombination deficiency in uterine leiomyosarcoma IM Collins, G Dall, CJ Vandenberg, K Nesic, G Ratnayake, W Zhu, ... | | 2023 |
| Patient vignettes reflecting the impact of The Australian Rare Cancer Portal on patients with Rare Cancer LA Papadopoulos, CL Georgiou, D Kee, C Reece, K Helen, B Allison, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 182-183, 2022 | | 2022 |
| The Australian Rare Cancer Portal: Outcomes from the implementation of a national rare cancer platform for referrals and research CL Georgiou, H Ke, LA Papadopoulos, D Kee, R Caldwell, J Haurat, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 58-59, 2022 | | 2022 |
| The psychosocial impact of the Australian Rare Cancer Portal on patients with rare cancer. L Papadopoulos, CL Georgiou, D Kee, R Caldwell, A Bourne, J Haurat, ... Journal of Clinical Oncology 40 (16_suppl), e24127-e24127, 2022 | | 2022 |
| Two years of the Australian Rare Cancer Portal: a national referral service for rare cancer information and research. CL Georgiou, D Kee, L Papadopoulos, R Caldwell, A Bourne, J Haurat, ... Journal of Clinical Oncology 40 (16_suppl), e18581-e18581, 2022 | | 2022 |
| The Australian Rare Cancer Portal: A retrospective review of referring oncologist's service requests R Caldwell, C Georgiou, D Kee, L Papadopoulos, M Krasovitsky, R Tay, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 105-106, 2021 | | 2021 |
| Delivering personalized care and research for rare cancers in the increasingly genomic world? CL Scott, R Lim, D Kee, C Georgiou, R Caldwell, L Papadopoulos, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 92-92, 2021 | | 2021 |
| The Australian rare cancer portal: An innovative online service co-ordinating national expert care for rare cancer patients CL Georgiou, D Kee, R Caldwell, MS Krasovitsky, R Tay, A Bourne, ... ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 29-29, 2021 | | 2021 |
| Survival of Uveal Melanoma Patients Treated With Combination and Single-Agent Immunotherapy R Caldwell, R Mason, V Atkinson Asia-Pacific Journal of Clinical Oncology 13 (s4), 140-141, 2017 | | 2017 |
| ADHERENCE BY UROLOGISTS TO THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) AND AMERICAN UROLOGICAL ASSOCIATION (AUA) RENAL CELL CARCINOMA (RCC) SURVEILLANCE GUIDELINES R Caldwell ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 11, 51-51, 2015 | | 2015 |
Johann de BonoInstitute of Cancer ResearchVerified email at icr.ac.uk
